gemcitabine has been researched along with alantolactone in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, B; Liu, X; Liu, Y; Wang, J; Zhang, Y | 1 |
1 other study(ies) available for gemcitabine and alantolactone
| Article | Year |
|---|---|
Alantolactone enhances gemcitabine sensitivity of lung cancer cells through the reactive oxygen species-mediated endoplasmic reticulum stress and Akt/GSK3β pathway.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Drug Resistance, Neoplasm; Endoplasmic Reticulum Stress; Gemcitabine; Glycogen Synthase Kinase 3 beta; Humans; Lactones; Lung Neoplasms; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Sesquiterpenes, Eudesmane; Signal Transduction | 2019 |